Association of adipokines with hepatic steatosis and fibrosis in chronic hepatitis B patients on long-term nucleoside analogue.

Loey Lung-Yi MakChi-Ho LeeKa-Shing CheungDanny Ka-Ho WongFen LiuRex Wan-Hin HuiJames Yan-Yue FungAimin XuKaren Siu-Ling LamMan Fung Yuen Wai Kay Seto

Published in: Liver international : official journal of the International Association for the Study of the Liver (2019)

Low FGF-21 and high AFABP levels were associated with advanced fibrosis/cirrhosis in CHB patients on antiviral treatment. Plasma AFABP, together with other metabolic risk factors, may aid identification of patients lacking fibrosis improvement during antiviral treatment.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
risk factors
prognostic factors
peritoneal dialysis
combination therapy